Multiplikator Forward P/S: IRIDEX Corp (IRIX)
IRIDEX Corporation dominates the ophthalmology sector thanks to MicroPulse, which ensures safe treatment for the retina and glaucoma. Checking the expected P/S ratio on GURU.Markets, we see that 0.20 serves as the base value for this parameter. Distribution growth is supported by training physicians to operate the Cyclo G6. High regulatory barriers and patent protection securely safeguard the brand's position in the global market.
Ringkesan rincian data analitis iridex.com (IRIX)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal IRIDEX Corporation|IRIX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal IRIDEX|IRIX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku IRIDEX Corporation|IRIX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan IRIDEX|Rasio cepet iridex.com
- rincian asil keuangan lan kelipatan valuasi:
IRIX - Penghasilan resik perusahaan|Bathi sing dikarepake IRIDEX Corporation|IRIX - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi IRIDEX|IRIX - Pangali PEG|Pangali EV/EBITDA IRIDEX Corporation|IRIX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan IRIDEX|IRIX - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan iridex.com|IRIX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep IRIDEX Corporation
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:IRIX (IRIDEX Corp.)
To assess the financial stability of IRIDEX Corporation (IRIX), investors must analyze the forward P/S ratio, which compares current market capitalization to expected revenue, reflecting the market's real-time assessment of business prospects. Amidst saturation in the laser equipment market, the forward P/S trend helps determine whether the company's valuation adequately accounts for the steady cash flow generated by the sale of microsurgery consumables.
Karo sapa IRIDEX Corporation saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|PFSA - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|GCTK: Rega forward marang dodolan|Multiplikator Forward P/S NAOV|Rasio kapitalisasi marang dodolan sing dikarepake Venus Concept Corporation|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|AEMD: Kapitalisasi marang prakiraan pendapatan|TransEnterix - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Avinger Inc.|BSGM (BioSig Technologies, Inc) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan CUTR|Multiplikator forward rega marang pendapatan KNW|NARI: Rega forward marang dodolan|Multiplikator Forward P/S NVRO|Multiplikator forward rega marang pendapatan reshapelifesciences.com RSLS|Rasio rega marang prakiraan pendapatan Silk Road Medical Inc. SILK
